Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Learning package: The new POSEIDON criteria

Learning package: The new POSEIDON criteria
  • Reproductive medicine
  • Fertility
Announcement
29 October 2017

A panel of experts (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number, the POSEIDON group) recently proposed new criteria to help guide the physician in handling POR patients.

These learning resources introduce the new POSEIDON criteria as a means to improve the management of patients exposed to assisted reproductive technologies (ART), and promote more specific approaches to patients with impaired prognosis during IVF, thereby offering better tools with which to optimize IVF success rates.

 

 


Poor ovarian response: The relationship between quantity and quality

Why The POSEIDON classification?, VIDEO LECTURE S. Esteves, Brazil

What is The POSEIDON classification?, VIDEO LECTURE P. Humaidan, Denmark

Markers of ovarian reserve: can we use them for daily clinical practice?, A. La Marca, Italy

From predict to treat

The impact of age on oocyte quality, VIDEO LECTURE A. Capalbo, Italy

The ART Calculator: estimating a new marker of success in ART, VIDEO LECTURE S. Esteves, Brazil

Management of The POSEIDON groups

POSEIDON Groups 1 - 2, VIDEO LECTURE C. Alviggi, Italy

POSEIDON Groups 3 - 4, VIDEO LECTURE P. Humaidan, Denmark

Strategy of accumulation in The POSEIDON groups, VIDEO LECTURE C. Alviggi, Italy

Practical case studies

Case studies 1-2, C. Alviggi, Italy

Case studies 3-4, P. Humaidan, Denmark

International workshop
Athens, Greece
Oct 13 - 14, 2017
Target audience
Clinicians, embryologists, biologists and scientists working in ART.
EACCME®
by Excemed
Reproductive medicine